Into this area of uncertainty, our study offers a novel and compelling insight, shifting the focus from the surgeon's hands to the anesthesiologist's domain. We meticulously analyzed 285 RARP cases at our center and uncovered a striking connection that had previously been overlooked: the amount of intravenous crystalloid fluid administered during surgery appears to be a significant factor in who develops a lymphocele.
We found that patients who received a more generous amount of fluids had a significantly higher rate of lymphocele formation. This association was not a subtle statistical trend; it was a strong signal (p < 0.001) that persisted even after we accounted for other potential confounders. In a multivariable model that included factors like the extent of lymph node dissection and a peritoneal flap procedure, the link between fluid dosage and lymphoceles remained. We noted no similar link for other major complications or anastomotic leakage, sharpening the focus specifically on the genesis of lymphoceles.
This finding provides a potential answer to the long-standing question of lymphocele pathogenesis. We hypothesize that flooding the system with crystalloid fluids has a dual effect. First, it directly increases the volume and flow of lymphatic fluid throughout the body. Second, it dilutes the blood, lowering the colloid osmotic pressure that helps keep fluid within the vessels. This combination may create a "perfect storm" where the surgically disrupted lymphatic channels are overwhelmed by increased flow and are less able to be sealed, leading to persistent microleakage that accumulates into a lymphocele.
This research identifies intraoperative fluid management as a new and, most importantly, a modifiable risk factor. While a surgeon cannot change a patient's BMI or the oncologic necessity of an extensive lymph node dissection, the anesthesiology and surgical team can collaboratively manage fluid administration. The study identified an optimal threshold of 7.73 ml/kg/h; patients receiving fluids above this rate were more than twice as likely to develop a lymphocele. After statistical matching to ensure the groups were comparable, the odds remained just as high.
While the vast majority of these lymphoceles were asymptomatic and detected on routine ultrasound, their prevention is a key goal, as a reduction in overall incidence is expected to reduce the number of symptomatic cases requiring intervention. We suggest that a more judicious or restrictive fluid strategy, perhaps aiming below the identified threshold, could be a simple yet effective protective measure, complementing established surgical techniques like creating a peritoneal flap. Whether the protective effect of this restrictive fluid strategy can be confirmed is a question that should now be addressed in external validation and ideally a prospective trial. It offers a fresh perspective, suggesting that the prevention of lymphoceles is a shared responsibility, with the anesthesiologist playing a newly illuminated and critical role.
Written by: Thomas Büttner,1 Marcus O. Thudium,2 Manuel Ritter,1 Stefan Hauser,1 Martin Söhle,2 Philipp Krausewitz1
- Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.
- Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.